126 days ago • Posted by Martin Boujol

AstraZeneca proven to be 79% in late-stage US trial

The AstraZeneca vaccine received a 79% safety score in its late-stage US trials. the company plans to file for an FDA authorization by mid-April.

Source: Wall Street Journal

#Stocks
AstraZeneca proven to be 79% in late-stage US trial
bg_nwsletter